Avantor Sees Unusually Large Options Volume (NYSE:AVTR)

Avantor, Inc. (NYSE:AVTR) was the recipient of unusually large options trading activity on Monday. Stock traders acquired 26,227 put options on the company. This is an increase of approximately 384% compared to the typical volume of 5,419 put options.

Institutional Investors Weigh In On Avantor

A number of large investors have recently bought and sold shares of AVTR. VisionPoint Advisory Group LLC grew its holdings in Avantor by 5.2% during the 4th quarter. VisionPoint Advisory Group LLC now owns 156,767 shares of the company’s stock worth $3,323,000 after acquiring an additional 7,771 shares during the last quarter. First Bank & Trust grew its stake in shares of Avantor by 6.3% during the fourth quarter. First Bank & Trust now owns 18,899 shares of the company’s stock valued at $398,000 after purchasing an additional 1,117 shares during the last quarter. Global Retirement Partners LLC increased its holdings in shares of Avantor by 76.7% in the fourth quarter. Global Retirement Partners LLC now owns 2,459 shares of the company’s stock valued at $52,000 after purchasing an additional 1,067 shares in the last quarter. Peregrine Capital Management LLC raised its position in Avantor by 20.7% in the 4th quarter. Peregrine Capital Management LLC now owns 857,538 shares of the company’s stock worth $18,068,000 after purchasing an additional 147,202 shares during the last quarter. Finally, Venturi Wealth Management LLC boosted its position in Avantor by 504.8% in the 4th quarter. Venturi Wealth Management LLC now owns 7,572 shares of the company’s stock valued at $160,000 after buying an additional 6,320 shares during the last quarter. 95.08% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

AVTR has been the topic of a number of research reports. UBS Group reaffirmed a “neutral” rating and set a $25.00 target price (down previously from $29.00) on shares of Avantor in a research report on Friday, January 17th. Robert W. Baird dropped their price objective on shares of Avantor from $27.00 to $26.00 and set an “outperform” rating on the stock in a report on Monday, October 28th. Barclays increased their target price on shares of Avantor from $25.00 to $26.00 and gave the company an “overweight” rating in a research note on Monday. Raymond James lowered their price target on Avantor from $29.00 to $26.00 and set an “outperform” rating on the stock in a research note on Tuesday, January 21st. Finally, Wells Fargo & Company reduced their price objective on Avantor from $30.00 to $28.00 and set an “overweight” rating for the company in a research report on Monday, October 28th. Three equities research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $27.46.

Avantor Price Performance

NYSE:AVTR traded down $0.27 on Monday, reaching $22.02. The stock had a trading volume of 3,534,292 shares, compared to its average volume of 4,685,844. The company has a market capitalization of $14.98 billion, a P/E ratio of 47.93, a price-to-earnings-growth ratio of 3.97 and a beta of 1.28. The stock has a fifty day moving average price of $21.69 and a 200-day moving average price of $23.46. The company has a quick ratio of 1.06, a current ratio of 1.54 and a debt-to-equity ratio of 0.84. Avantor has a 1-year low of $19.59 and a 1-year high of $28.00.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.